10x Genomics (TXG)
(Delayed Data from NSDQ)
$27.59 USD
+0.69 (2.57%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $27.92 +0.33 (1.20%) 7:58 PM ET
2-Buy of 5 2
D Value A Growth B Momentum B VGM
Price, Consensus and EPS Surprise
TXG 27.59 +0.69(2.57%)
Will TXG be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for TXG based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for TXG
3 Medical Products Stocks Set to Beat This Earnings Season
Down -23.92% in 4 Weeks, Here's Why 10x Genomics (TXG) Looks Ripe for a Turnaround
TXG: What are Zacks experts saying now?
Zacks Private Portfolio Services
10x Genomics (TXG) Expected to Beat Earnings Estimates: Should You Buy?
10x Genomics (TXG) Upgraded to Buy: Here's What You Should Know
Here's What Key Metrics Tell Us About 10x Genomics (TXG) Q4 Earnings
Other News for TXG
Terex (TEX) Receives a Rating Update from a Top Analyst
Truist Financial Sticks to Its Buy Rating for Terex (TEX)
Terex Sell Rating Justified by Regional Challenges and Uncertain Growth Prospects
Terex Analysis: Hold Rating Amid Declining Orders and Mixed Financial Signals
Terex Schedules Q1 2024 Financial Results Review Call